Evidence map›Paper›PMID 40645980›Full record

ArticleNature communications2025

Multicolored sequential resonance energy transfer for detection of simultaneous ligand binding at G protein-coupled receptors.

Alice Valentini, Bethany Dibnah, Marija Ciba, Elaine M Duncan, Asmita Manandhar, Bethany Strellis, Luca Vita, Olivia Lucianno, Conor Massey, Sophie Coe and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alice ValentiniDepartment of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, Copenhagen, DK-2100, Denmark.
Bethany DibnahCentre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom.
Marija CibaDepartment of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, Copenhagen, DK-2100, Denmark.
Elaine M DuncanCentre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom.
Asmita ManandharDepartment of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, Copenhagen, DK-2100, Denmark.
Bethany StrellisCentre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom.ORCID http://orcid.org/0000-0003-3303-9107
Luca VitaCentre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom.
Olivia LuciannoCentre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom.
Conor MasseyCentre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom.
Sophie CoeCentre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom.
Trond UlvenDepartment of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, Copenhagen, DK-2100, Denmark.ORCID http://orcid.org/0000-0002-8135-1755
Brian D HudsonCentre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom. Brian.Hudson@Glasgow.ac.uk.ORCID http://orcid.org/0000-0001-7059-0091
Elisabeth Rexen UlvenDepartment of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, Copenhagen, DK-2100, Denmark. eru@sund.ku.dk.ORCID http://orcid.org/0000-0003-1243-7587

Funding

Academy of Medical Sciences SBF004\1033Lundbeckfonden (Lundbeck Foundation) R307-2018-2950Medical Research Scotland PHD-50838-2024RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/X010902/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/S02347X/1Tenovus S18-20
6 · The paper itself

Abstract

G protein coupled-receptors (GPCRs) are the largest family of signalling proteins and highly successful drug targets. Most GPCR targeting drugs interact with a binding pocket for the natural ligand of the receptor, typically near the extracellular region of the transmembrane domains. Advancements in structural biology have identified additional allosteric binding sites in other parts of these receptors. Allosteric sites provide theoretical advantages, including the ability to modulate natural ligand function, and there is a need for better ways to study how ligands interact with these different GPCR binding sites. Here we have developed an approach to study multiple ligands binding to the same GPCR at the same time based on sequential resonance energy transfer between two fluorescent ligands. We use this approach to define ligand pharmacology and to understand binding kinetics at the FFA1 free fatty acid receptor, a clinically relevant receptor. This approach to study GPCR ligand interactions will aid development of new GPCR drugs.

Indexed as

Fluorescence Resonance Energy TransferReceptors, G-Protein-CoupledAllosteric SiteBinding SitesHEK293 CellsHumansKineticsLigandsProtein BindingFFAR1 protein, humanLigandsReceptors, G-Protein-Coupled

Identifiers

PMID40645980
PMCPMC12254266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.